CD27 anticorps (full length)

N° du produit ABIN7877852

Cet anticorps Souris Monoclonal détecte spécifiquement CD27 dans FACS, ELISA, IF et IHC (p). Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour CD27 anticorps (full length) (ABIN7877852)

Antigène: CD27 (CD27 Molecule (CD27))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD27 est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: LPFS2-1611

Détail du produit anti-CD27 anticorps

Épitope: full length

Fonction: CD27 Antibody (azide and preservative free)

Purification: Protein G affinity chromatography

Immunogène: A recombinant full-length human CD27 protein was used as the immunogen for this CD27 antibody.

Isotype: IgG1, kappa

Information d'application

Indications d'application: Optimal dilution of the CD27 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the CD27 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur CD27

Antigène: CD27 (CD27 Molecule (CD27))

Autre désignation: CD27

Sujet: Recognizes a protein of a disulfide-linked 120 kDa dimer, identified as CD27. It is expressed on the majority of peripheral T cells, medullary thymocytes, memory-type B cells, and natural killer cells. It is a transmembrane phosphoglycoprotein that belongs to the tumor necrosis factor receptor (TNFR) superfamily. CD27 binds to its ligand CD70, a member of the TNF family, and induces T-cell co-stimulation and B-cell activation. It also interacts with TRAFs and is involved in activation of NFB and SAPK/JNK and induces apoptosis.

UniProt: P26842

Pathways: Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints